Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network.
Sue HauptFranco CaramiaAlan HerschtalThierry SoussiGuillermina LozanoHu ChenHan LiangTerence P SpeedYgal HauptPublished in: Nature communications (2019)
The disproportionately high prevalence of male cancer is poorly understood. We tested for sex-disparity in the functional integrity of the major tumor suppressor p53 in sporadic cancers. Our bioinformatics analyses expose three novel levels of p53 impact on sex-disparity in 12 non-reproductive cancer types. First, TP53 mutation is more frequent in these cancers among US males than females, with poorest survival correlating with its mutation. Second, numerous X-linked genes are associated with p53, including vital genomic regulators. Males are at unique risk from alterations of their single copies of these genes. High expression of X-linked negative regulators of p53 in wild-type TP53 cancers corresponds with reduced survival. Third, females exhibit an exceptional incidence of non-expressed mutations among p53-associated X-linked genes. Our data indicate that poor survival in males is contributed by high frequencies of TP53 mutations and an inability to shield against deregulated X-linked genes that engage in p53 networks.
Keyphrases
- papillary thyroid
- bioinformatics analysis
- genome wide
- squamous cell
- childhood cancer
- genome wide identification
- wild type
- poor prognosis
- transcription factor
- copy number
- squamous cell carcinoma
- lymph node metastasis
- gene expression
- electronic health record
- binding protein
- network analysis
- amyotrophic lateral sclerosis